These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37449317)

  • 21. Exploratory analysis of glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 in management of patients with mild neurological symptoms undergoing head computed tomography scan at the emergency department: a pilot study from a Croatian tertiary hospital.
    Lapić I; Rogić D; Lončar Vrančić A; Gornik I
    Lab Med; 2024 Jul; 55(4):492-497. PubMed ID: 38363974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Are Not Specific Biomarkers for Mild CT-Negative Traumatic Brain Injury.
    Posti JP; Hossain I; Takala RS; Liedes H; Newcombe V; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    J Neurotrauma; 2017 Jan; ():. PubMed ID: 27841729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study protocol for investigating the performance of an automated blood test measuring GFAP and UCH-L1 in a prospective observational cohort of patients with mild traumatic brain injury: European BRAINI study.
    Richard M; Lagares A; Bondanese V; de la Cruz J; Mejan O; Pavlov V; Payen JF;
    BMJ Open; 2021 Feb; 11(2):e043635. PubMed ID: 33632753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury.
    Kobeissy F; Arja RD; Munoz JC; Shear DA; Gilsdorf J; Zhu J; Yadikar H; Haskins W; Tyndall JA; Wang KK
    Expert Rev Mol Diagn; 2024; 24(1-2):67-77. PubMed ID: 38275158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
    Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
    J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
    World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions.
    Biberthaler P; Musaelyan K; Krieg S; Meyer B; Stimmer H; Zapf J; von Matthey F; Chandran R; Marino JA; Beligere G; Hoffmann M; Zhang H; Datwyler SA; McQuiston B
    Neurotrauma Rep; 2021; 2(1):617-625. PubMed ID: 35018363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are UCH-L1 and GFAP promising biomarkers for children with mild traumatic brain injury?
    Rhine T; Babcock L; Zhang N; Leach J; Wade SL
    Brain Inj; 2016; 30(10):1231-8. PubMed ID: 27416022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
    Lange RT; Lippa S; Brickell TA; Gill J; French LM
    J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Performance of Traumatic Brain Injury Biomarkers in High-Risk Elderly Patients.
    Ward MD; Weber A; Merrill VD; Welch RD; Bazarian JJ; Christenson RH
    J Appl Lab Med; 2020 Jan; 5(1):91-100. PubMed ID: 32445344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of GFAP and UCH-L1 Measurements Using Two Automated Immunoassays (i-STAT
    Oris C; Khatib-Chahidi C; Pereira B; Bailly Defrance V; Bouvier D; Sapin V
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Narrative Review of Existing and Developing Biomarkers in Acute Traumatic Brain Injury for Potential Military Deployed Use.
    Kocik VI; Dengler BA; Rizzo JA; Ma Moran M; Willis AM; April MD; Schauer SG
    Mil Med; 2024 May; 189(5-6):e1374-e1380. PubMed ID: 37995274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study.
    Åkerlund CAI; Holst A; Bhattacharyay S; Stocchetti N; Steyerberg E; Smielewski P; Menon DK; Ercole A; Nelson DW;
    Lancet Neurol; 2024 Jan; 23(1):71-80. PubMed ID: 37977157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury.
    Papa L; Brophy GM; Alvarez W; Hirschl R; Cress M; Weber K; Giordano P
    Sci Rep; 2023 Jul; 13(1):11833. PubMed ID: 37481589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood Biomarkers for the Management of Mild Traumatic Brain Injury in Clinical Practice.
    Oris C; Kahouadji S; Bouvier D; Sapin V
    Clin Chem; 2024 Aug; 70(8):1023-1036. PubMed ID: 38656380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combining biochemical and imaging markers to improve diagnosis and characterization of mild traumatic brain injury in the acute setting: results from a pilot study.
    Kou Z; Gattu R; Kobeissy F; Welch RD; O'Neil BJ; Woodard JL; Ayaz SI; Kulek A; Kas-Shamoun R; Mika V; Zuk C; Tomasello F; Mondello S
    PLoS One; 2013; 8(11):e80296. PubMed ID: 24260364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood-Based Protein Biomarkers for the Management of Traumatic Brain Injuries in Adults Presenting to Emergency Departments with Mild Brain Injury: A Living Systematic Review and Meta-Analysis.
    Mondello S; Sorinola A; Czeiter E; Vámos Z; Amrein K; Synnot A; Donoghue E; Sándor J; Wang KKW; Diaz-Arrastia R; Steyerberg EW; Menon DK; Maas AIR; Buki A
    J Neurotrauma; 2021 Apr; 38(8):1086-1106. PubMed ID: 29020853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of Blood Biomarkers of Traumatic Brain Injury.
    Rezaii PG; Grant GA; Zeineh MM; Richardson KJ; Coburn ML; Bet AM; Weber A; Jiang B; Li Y; Ubungen K; Routh G; Wheatcroft AM; Paulino AD; Hayes RL; Steinberg GK; Wintermark M
    J Neurotrauma; 2019 Aug; 36(16):2407-2416. PubMed ID: 30968744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Biomarkers of Neuronal Injury and Inflammation With Insomnia Trajectories After Traumatic Brain Injury: A TRACK-TBI Study.
    Werner JK; Albrecht J; Capaldi VF; Jain S; Sun X; Mukherjee P; Williams SG; Collen J; Diaz-Arrastia R; Manley GT; Krystal AD; Wickwire E;
    Neurology; 2024 Apr; 102(8):e209269. PubMed ID: 38547447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.